Client News
Data on the antimicrobial activity of XF-73 against bacteria within biofilms to be presented at prestigious 2022 ECCMID Congress
HepaRegeniX appoints Elias Papatheodorou as new Chairman of the Board of Directors
Adocia strengthens its cash position by 19 million euros following a real estate transaction
Atriva Therapeutics announces efficacy of its lead compound zapnometinib against Omicron
InflaRx Reports Full Year 2021 Financial and Operating Results
Heidelberg Pharma Announces Financial Figures for Fiscal Year 2021 and Provides Business Update
Atriva Therapeutics announces changes in its Management Team
InflaRx Receives Corrected Advice Letter from FDA Related to Phase III Program for Vilobelimab in Hidradenitis Suppurativa
Abivax reports 2021 financial results and operations update
